Ibrahima Diouf

Ibrahima Diouf

Auto-generated profile, based on publicly available information

Ibrahima Diouf

Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Melbourne, Australia

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2019 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
SAScott Ayton
Scott Ayton
YWYamin Wang
Yamin Wang
IDIbrahima Diouf
Ibrahima Diouf
JSJulie A. Schneider
Julie A. Schneider
JBJohn Brockman
John Brockman
Ashley I. BushAshley I. Bush
Ashley I. Bush

24 July 2017 in Brain
Verified
Journal Article
Open access
PDF file
SAScott Ayton
Scott Ayton
AFAmir Fazlollahi
Amir Fazlollahi
PBPierrick Bourgeat
Pierrick Bourgeat
PRParnesh Raniga
Parnesh Raniga
ANAmanda Ng
Amanda Ng
Ashley I. BushAshley I. Bush
Ashley I. Bush
See Derry and Kent (doi: 10.1093/awx167 ) for a scientific commentary on this article. The large variance in cognitive deterioration in subjects who test positive for amyloid-β by positron emission tomography indicates that convergent pathologies, such as iron accumulation, might combine with amyloid-β to accelerate Alzheimer’s disease progression. Here, we applied quantitative susceptibility mapping, a relatively new magnetic resonance imaging method sensitive to tissue iron, to assess the relationship between iron, amyloid-β load, and cognitive decline in 117 subjects who underwent baseline magnetic resonance imaging and amyloid-β positron emission tomography from the Australian Imaging, Biomarkers and Lifestyle study (AIBL). Cognitive function data were collected every 18 months for up to 6 years from 100 volunteers who were either cognitively normal (n = 64) or diagnosed with mild cognitive impairment (n = 17) or Alzheimer’s disease (n = 19). Among participants with amyloid pathology (n = 45), higher hippocampal quantitative susceptibility mapping levels predicted accelerated deterioration in composite cognition tests for episodic memory [β(standard error) = −0.169 (0.034), P = 9.2 × 10−7], executive function [β(standard error) = −0.139 (0.048), P = 0.004), and attention [β(standard error) = −0.074 (0.029), P = 0.012]. Deteriorating performance in a composite of language tests was predicted by higher quantitative susceptibility mapping levels in temporal lobe [β(standard error) = −0.104 (0.05), P = 0.036] and frontal lobe [β(standard error) = −0.154 (0.055), P = 0.006]. These findings indicate that brain iron might combine with amyloid-β to accelerate clinical progression and that quantitative susceptibility mapping could be used in combination with amyloid-β positron emission tomography to stratify individuals at risk of decline.

1 May 2010 in Epidemiology
Verified
Journal Article
Closed access
IDIbrahima Diouf
Ibrahima Diouf
MCMarie Aline Charles
Marie Aline Charles
PDPierre Ducimetière
Pierre Ducimetière
ABArnaud Basdevant
Arnaud Basdevant
EEEvelyne Eschwege
Evelyne Eschwege
BHBarbara Heude
Barbara Heude
Background: A rapid increase in the prevalence of obesity has been reported in France since 1990. We investigated the impact of birth cohort on the changes in obesity prevalence after taking into account age and survey period. Methods: We analyzed data from 4 national surveys in 1997, 2000, 2003, and 2006. For each survey, self-reported data on weight and height were recorded on mailed questionnaires sent to a sample of 20,000 households, representative of the French population. Obesity was defined according to World Health Organization criteria as body mass index ≥30 kg/m2. We modeled the prevalence of obesity using logistic regression with age, cohort, and period as explanatory variables. As these variables are linearly dependent, only nonlinear effects can be estimated uniquely and interpreted, after including specific chosen constraints in the models. Results: There was a progressive increase in the prevalence of obesity between 1997 and 2006, attributable either to a period effect or to a cohort effect. There was a substantial departure from a linear trend for the cohort effect only, which seemed to be stronger in women: there was an acceleration in the prevalence of obesity with birth cohort for individuals born after the mid-1960s, in both sexes. Conclusions: Our results are consistent with previous studies in other countries. Compared with older generations, men and women born in the late 1960s may have been subject to early exposures that increased their lifelong susceptibility to obesity.

22 September 2017 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Closed access
PDF file
SAScott Ayton
Scott Ayton
IDIbrahima Diouf
Ibrahima Diouf
Ashley I. BushAshley I. Bush
Ashley I. Bush
Objective: To investigate whether cerebrospinal fluid (CSF) ferritin (reporting brain iron) is associated with longitudinal changes in CSF β-amyloid (Aβ) and tau.Methods: Mixed-effects models of CSF Aβ1-42 and tau were constructed using data from 296 participants who had baseline measurement of CSF ferritin and annual measurement of CSF tau and Aβ1-42 for up to 5 years.Results: In subjects with biomarker-confirmed Alzheimer’s pathology, high CSF ferritin (>6.2 ng/mL) was associated with accelerated depreciation of CSF Aβ1-42 (reporting increased plaque formation; p=0.0001). CSF ferritin was neither associated with changes in CSF tau in the same subjects, nor longitudinal changes in CSF tau or Aβ1-42 in subjects with low baseline pathology. In simulation modelling of the natural history of Aβ deposition, which we estimated to occur over 31.4 years, we predicted that it would take 12.6 years to reach the pathology threshold value of CSF Aβ from healthy normal levels, and this interval is not affected by CSF ferritin. CSF ferritin influences the fall in CSF Aβ over the next phase, where high CSF ferritin accelerated the transition from threshold preclinical Aβ levels to the average level of Alzheimer’s subjects from 18.8 to 10.8 years.Conclusions: Iron might facilitate Aβ deposition in Alzheimer’s and accelerate the disease process.

8 January 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
VRVahid Riahi
Vahid Riahi
IDIbrahima Diouf
Ibrahima Diouf
SKSankalp Khanna
Sankalp Khanna
JBJustin Boyle
Justin Boyle
HHHamed Hassanzadeh
Hamed Hassanzadeh
Background: The health care industry must align with new digital technologies to respond to existing and new challenges. Digital twins (DTs) are an emerging technology for digital transformation and applied intelligence that is rapidly attracting attention. DTs are virtual representations of products, systems, or processes that interact bidirectionally in real time with their actual counterparts. Although DTs have diverse applications from personalized care to treatment optimization, misconceptions persist regarding their definition and the extent of their implementation within health systems. Objective: This study aimed to review DT applications in health care, particularly for clinical decision-making (CDM) and operational decision-making (ODM). It provides a definition and framework for DTs by exploring their unique elements and characteristics. Then, it assesses the current advances and extent of DT applications to support CDM and ODM using the defined DT characteristics. Methods: We conducted a scoping review following the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) protocol. We searched multiple databases, including PubMed, MEDLINE, and Scopus, for original research articles describing DT technologies applied to CDM and ODM in health systems. Papers proposing only ideas or frameworks or describing DT capabilities without experimental data were excluded. We collated several available types of information, for example, DT characteristics, the environment that DTs were tested within, and the main underlying method, and used descriptive statistics to analyze the synthesized data. Results: Out of 5537 relevant papers, 1.55% (86/5537) met the predefined inclusion criteria, all published after 2017. The majority focused on CDM (75/86, 87%). Mathematical modeling (24/86, 28%) and simulation techniques (17/86, 20%) were the most frequently used methods. Using International Classification of Diseases, 10th Revision coding, we identified 3 key areas of DT applications as follows: factors influencing diseases of the circulatory system (14/86, 16%); health status and contact with health services (12/86, 14%); and endocrine, nutritional, and metabolic diseases (10/86, 12%). Only 16 (19%) of 86 studies tested the developed system in a real environment, while the remainder were evaluated in simulated settings. Assessing the studies against defined DT characteristics reveals that the developed systems have yet to materialize the full capabilities of DTs. Conclusions: This study provides a comprehensive review of DT applications in health care, focusing on CDM and ODM. A key contribution is the development of a framework that defines important elements and characteristics of DTs in the context of related literature. The DT applications studied in this paper reveal encouraging results that allow us to envision that, in the near future, they will play an important role not only in the diagnosis and prevention of diseases but also in other areas, such as efficient clinical trial design, as well as personalized and optimized treatments.

1 April 2019 in Neurobiology of Disease
Verified
Journal Article
Closed access
IDIbrahima Diouf
Ibrahima Diouf
AFAmir Fazlollahi
Amir Fazlollahi
Ashley I. BushAshley I. Bush
Ashley I. Bush
SAScott Ayton
Scott Ayton